🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07808190
Starting soon Not applicable

HD-tACS for Alcohol Use Disorder

NCT07808190 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Mental Health Center
Phase
Not applicable
Started
2026-09-01
Last updated
2026-09-08

Condition(s) studied

Alcohol Use Disorder

Investigational drug(s) / intervention(s)

HD-tACSSham HD-tACS

HD-tACS: The stimulation parameters are 40Hz and 2mA. The stimulation protocol is 20 minutes per session, 3 times per day, for a total of 10 consecutive days.

Sham HD-tACS: The stimulation parameters are 40Hz and 2mA. The stimulation protocol is 20 minutes per session, 3 times per day, for a total of 10 consecutive days. At the commencement and conclusion of each therapeutic session, a 30-second ramp-up stimulation and a 30-second ramp-down stimulation (totaling 60 seconds) are administered, respectively, while the current output of the device is maintained at zero throughout the intervening interval.

Study summary

This study aims to systematically explore the effectiveness of accelerated HD-tACS in treating AUD, particularly its efficacy in reducing alcohol craving and preventing relapse in AUD patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Age range: 18-55 years old, gender not restricted; * Meets the DSM-5 diagnostic criteria for alcohol use disorder (moderate to severe); * AUDIT score ≥ 16; * Baseline score after alcohol cue-induced stimulation is ≥ 3; * Completed detoxification treatment before enrollment (moderate to severe), with detoxification duration of ≥ 7 days and ≤ 90 days; * Has a primary school education or above, and can understand and complete the research assessment; * Voluntarily participated in the study and signed the informed consent form. Exclusion Criteria: * Currently, there are other substance use disorders (except nicotine); * Currently, there are schizophrenia, bipolar disorder or other severe psychotic disorders; * Has a history of epilepsy or family history of epilepsy; * Has a history of brain trauma, brain surgery or intracranial metal implants; * Has received electroconvulsive therapy (ECT), transcranial electrical/magnetic/ultrasound stimulation within the past 6 months; * Pregnant or lactating women; * Other situations that the researchers consider unsuitable for participation in this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Mental Health Center Shanghai Shanghai Municipality

More Shanghai Mental Health Center trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07808190 on ClinicalTrials.gov ↗ ← All trials in China